Detailed Information on Publication Record
2005
Treatment of acute agitation in psychotic disorders
MOHR, Pavel, Ján PEČEŇÁK, Jaromír ŠVESTKA and T. TREUERBasic information
Original name
Treatment of acute agitation in psychotic disorders
Name in Czech
Diskuse o léčbě akutního psychotického onemocnění
Authors
MOHR, Pavel, Ján PEČEŇÁK, Jaromír ŠVESTKA and T. TREUER
Edition
Neuroendocrinology Letters, Sweden, Stockholm, Maghira and Maas Publications, 2005, 0172-780X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.005
Organization unit
Faculty of Medicine
UT WoS
000233233000013
Keywords in English
agitation; schizophreni; second generation antipsychotics; olanzapine; ziprasidone
Změněno: 30/6/2009 10:52, prof. MUDr. Eva Češková, CSc.
V originále
Several psychotic disorders, including schizophrenia, may be associated with symptoms of acute agitation and aggression. While drug treatment of agitation is often essential, non-pharmacological interventions, both environmental and behavioral, also play important roles in the complex management of agitated patients. The most extensively used psychotropic drugs are parenteral. formulas of conventional antipsychotics and benzodiazepines. Recently, injection forms of two second generation antipsychotics, olanzapine and ziprasidone, have become available. Both drugs have shown adequate efficacy and tolerability in several double-blind trials of intramuscular administration in acutely agitated psychotic patients. Compared to conventional medication, injection forms of the new antipsychotics may have a faster onset of action and more favorable profile of adverse events. Alternative approaches to injection administration include liquid drug formula, orally disintegrating tablets and wafers, treatment initiation with high doses, or rapid dose escalation. Evidence suggests that second-generation antipsychotics should be among the first-line choices in the treatment of agitation in acute psychosis.
In Czech
Článek popisuje zkušenosti a výstupy z odborných studií, prováděných na psychiatrických klinikách v různých zemích. Nabízí různé pohledy a diskusi